학술논문
SO-36 An immune-related gene expression profile predicts the efficacy of adding atezolizumab to first-line FOLFOXIRI/bevacizumab in metastatic colorectal cancer: A translational analysis of the phase II randomized AtezoTRIBE study
Document Type
Abstract
Author
Source
In Annals of Oncology June 2022 33 Supplement 4:S372-S372
Subject
Language
ISSN
0923-7534